Concepedia

Jos Cals

JC

3

Publications

121

Citations

3

H-Index

1997

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Jos Cals is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacotherapy, drug discovery, and medicinal chemistry.

Top concepts

Publications per year

1997–2020

3

Publications

3

A new cleavage strategy for the solid-phase synthesis of secondary amines

Paolo Conti, Dennis Demont, Jos Cals et al. · Tetrahedron Letters · 1997 · 61 citations

, , +7

Discovery and Optimization of 1-(4-(Pyridin-2-yl)benzyl)imidazolidine-2,4-dione Derivatives As a Novel Class of Selective Cannabinoid CB2 Receptor Agonists

Mario van der Stelt, Jos Cals, Silvia Broeders-Josten et al. · Journal of Medicinal Chemistry · 2011 · 36 citations · Full text

, , +12

Discovery of <i>N</i>-(Indazol-3-yl)piperidine-4-carboxylic Acids as RORγt Allosteric Inhibitors for Autoimmune Diseases

Hongjun Zhang, Blair T. Lapointe, Neville J. Anthony et al. · ACS Medicinal Chemistry Letters · 2020 · 24 citations · Full text

Rows per page

1–3 of 3